Not exact matches
For this analysis, 605 patients with newly diagnosed multiple myeloma and treated with continuous lenalidomide (brand name Revlimid)
following autologous stem cell
transplant were compared to 604 patients who were treated with placebo or no maintenance.
«Lenalidomide maintenance
following autologous stem cell
transplant can now be considered a standard of care for people with multiple myeloma,» says Dr. McCarthy, senior author on the meta - analysis and Principal Investigator of the U.S. study, CALGB (Alliance) 100104.
Dr. Goodman is also involved in collaborative efforts with the San Antonio Bone Marrow
Transplant Center to study the outcome of allogeneic bone marrow
transplants following a relapse from
autologous bone marrow
transplants.
As Dr. Maharaj explained, «One last option for Gale was high dose chemotherapy
followed by an
autologous bone marrow stem cell
transplant.